Global Equine Pharmaceuticals and Supplements Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Equine Pharmaceuticals and Supplements Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Equine Pharmaceuticals and Supplements Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Equine Pharmaceuticals and Supplements Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Pharmaceuticals
1.2.3 Supplements
1.3 Market Analysis by Application
1.3.1 Overview: Global Equine Pharmaceuticals and Supplements Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Thoroughbred Horse
1.3.3 Other Types of Horses
1.4 Global Equine Pharmaceuticals and Supplements Market Size & Forecast
1.4.1 Global Equine Pharmaceuticals and Supplements Sales in Value (2016-2026))
1.4.2 Global Equine Pharmaceuticals and Supplements Sales in Volume (2016-2026)
1.4.3 Global Equine Pharmaceuticals and Supplements Price by Type (2016-2026) & (USD/Unit)
1.5 Global Equine Pharmaceuticals and Supplements Production Capacity Analysis
1.5.1 Global Equine Pharmaceuticals and Supplements Total Production Capacity (2016-2026)
1.5.2 Global Equine Pharmaceuticals and Supplements Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Equine Pharmaceuticals and Supplements Market Drivers
1.6.2 Equine Pharmaceuticals and Supplements Market Restraints
1.6.3 Equine Pharmaceuticals and Supplements Trends Analysis
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product and Services
2.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Merck Animal Health
2.2.1 Merck Animal Health Details
2.2.2 Merck Animal Health Major Business
2.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product and Services
2.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business
2.3.3 Zoetis Equine Pharmaceuticals and Supplements Product and Services
2.3.4 Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Bayer Animal Health
2.4.1 Bayer Animal Health Details
2.4.2 Bayer Animal Health Major Business
2.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product and Services
2.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Elanco Animal Health
2.5.1 Elanco Animal Health Details
2.5.2 Elanco Animal Health Major Business
2.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product and Services
2.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Dechra Veterinary Products
2.6.1 Dechra Veterinary Products Details
2.6.2 Dechra Veterinary Products Major Business
2.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product and Services
2.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 CEVA
2.7.1 CEVA Details
2.7.2 CEVA Major Business
2.7.3 CEVA Equine Pharmaceuticals and Supplements Product and Services
2.7.4 CEVA Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Virbac
2.8.1 Virbac Details
2.8.2 Virbac Major Business
2.8.3 Virbac Equine Pharmaceuticals and Supplements Product and Services
2.8.4 Virbac Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Norbrook Equine
2.9.1 Norbrook Equine Details
2.9.2 Norbrook Equine Major Business
2.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product and Services
2.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Kyoritsu Seiyaku
2.10.1 Kyoritsu Seiyaku Details
2.10.2 Kyoritsu Seiyaku Major Business
2.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product and Services
2.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Vetoquinol
2.11.1 Vetoquinol Details
2.11.2 Vetoquinol Major Business
2.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product and Services
2.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Protexin Healthcare
2.12.1 Protexin Healthcare Details
2.12.2 Protexin Healthcare Major Business
2.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product and Services
2.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Audevard
2.13.1 Audevard Details
2.13.2 Audevard Major Business
2.13.3 Audevard Equine Pharmaceuticals and Supplements Product and Services
2.13.4 Audevard Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Ouro Fino Saude
2.14.1 Ouro Fino Saude Details
2.14.2 Ouro Fino Saude Major Business
2.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product and Services
2.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Equine Pharmaceuticals and Supplements Sales by Manufacturer
3.1 Global Equine Pharmaceuticals and Supplements Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Equine Pharmaceuticals and Supplements
3.4 Market Concentration Rate
3.4.1 Top 3 Equine Pharmaceuticals and Supplements Manufacturer Market Share
3.4.2 Top 6 Equine Pharmaceuticals and Supplements Manufacturer Market Share
3.5 Global Equine Pharmaceuticals and Supplements Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Equine Pharmaceuticals and Supplements Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Equine Pharmaceuticals and Supplements Market Size by Region
4.1.1 Global Equine Pharmaceuticals and Supplements Sales in Volume by Region (2016-2026)
4.1.2 Global Equine Pharmaceuticals and Supplements Revenue by Region (2016-2026)
4.2 North America Equine Pharmaceuticals and Supplements Revenue (2016-2026)
4.3 Europe Equine Pharmaceuticals and Supplements Revenue (2016-2026)
4.4 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue (2016-2026)
4.5 South America Equine Pharmaceuticals and Supplements Revenue (2016-2026)
4.6 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Equine Pharmaceuticals and Supplements Sales in Volume by Type (2016-2026)
5.2 Global Equine Pharmaceuticals and Supplements Revenue by Type (2016-2026)
5.3 Global Equine Pharmaceuticals and Supplements Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Equine Pharmaceuticals and Supplements Sales in Volume by Application (2016-2026)
6.2 Global Equine Pharmaceuticals and Supplements Revenue by Application (2016-2026)
6.3 Global Equine Pharmaceuticals and Supplements Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Equine Pharmaceuticals and Supplements Sales by Type (2016-2026)
7.2 North America Equine Pharmaceuticals and Supplements Sales by Application (2016-2026)
7.3 North America Equine Pharmaceuticals and Supplements Market Size by Country
7.3.1 North America Equine Pharmaceuticals and Supplements Sales in Volume by Country (2016-2026)
7.3.2 North America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Equine Pharmaceuticals and Supplements Sales by Type (2016-2026)
8.2 Europe Equine Pharmaceuticals and Supplements Sales by Application (2016-2026)
8.3 Europe Equine Pharmaceuticals and Supplements Market Size by Country
8.3.1 Europe Equine Pharmaceuticals and Supplements Sales in Volume by Country (2016-2026)
8.3.2 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (2016-2026)
9.2 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (2016-2026)
9.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Region
9.3.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Equine Pharmaceuticals and Supplements Sales by Type (2016-2026)
10.2 South America Equine Pharmaceuticals and Supplements Sales by Application (2016-2026)
10.3 South America Equine Pharmaceuticals and Supplements Market Size by Country
10.3.1 South America Equine Pharmaceuticals and Supplements Sales in Volume by Country (2016-2026)
10.3.2 South America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2016-2026)
11.2 Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2016-2026)
11.3 Middle East & Africa Equine Pharmaceuticals and Supplements Market Size by Country
11.3.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Equine Pharmaceuticals and Supplements Typical Distributors
12.3 Equine Pharmaceuticals and Supplements Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Equine Pharmaceuticals and Supplements Revenue by Type, (USD Million), 2021-2026
Table 2. Global Equine Pharmaceuticals and Supplements Revenue by Application, (USD Million), 2021-2026
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product and Services
Table 6. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 8. Merck Animal Health Major Business
Table 9. Merck Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 10. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Zoetis Basic Information, Manufacturing Base and Competitors
Table 12. Zoetis Major Business
Table 13. Zoetis Equine Pharmaceuticals and Supplements Product and Services
Table 14. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer Animal Health Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Animal Health Major Business
Table 17. Bayer Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 18. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 20. Elanco Animal Health Major Business
Table 21. Elanco Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 22. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Dechra Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 24. Dechra Veterinary Products Major Business
Table 25. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product and Services
Table 26. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. CEVA Basic Information, Manufacturing Base and Competitors
Table 28. CEVA Major Business
Table 29. CEVA Equine Pharmaceuticals and Supplements Product and Services
Table 30. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Virbac Basic Information, Manufacturing Base and Competitors
Table 32. Virbac Major Business
Table 33. Virbac Equine Pharmaceuticals and Supplements Product and Services
Table 34. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Norbrook Equine Basic Information, Manufacturing Base and Competitors
Table 36. Norbrook Equine Major Business
Table 37. Norbrook Equine Equine Pharmaceuticals and Supplements Product and Services
Table 38. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Kyoritsu Seiyaku Basic Information, Manufacturing Base and Competitors
Table 40. Kyoritsu Seiyaku Major Business
Table 41. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product and Services
Table 42. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 44. Vetoquinol Major Business
Table 45. Vetoquinol Equine Pharmaceuticals and Supplements Product and Services
Table 46. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Protexin Healthcare Basic Information, Manufacturing Base and Competitors
Table 48. Protexin Healthcare Major Business
Table 49. Protexin Healthcare Equine Pharmaceuticals and Supplements Product and Services
Table 50. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Audevard Basic Information, Manufacturing Base and Competitors
Table 52. Audevard Major Business
Table 53. Audevard Equine Pharmaceuticals and Supplements Product and Services
Table 54. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Ouro Fino Saude Basic Information, Manufacturing Base and Competitors
Table 56. Ouro Fino Saude Major Business
Table 57. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product and Services
Table 58. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Equine Pharmaceuticals and Supplements Sales by Manufacturer (2019-2021e) & (K Units)
Table 60. Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Equine Pharmaceuticals and Supplements, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Equine Pharmaceuticals and Supplements Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Equine Pharmaceuticals and Supplements Production Site of Key Manufacturer
Table 64. Equine Pharmaceuticals and Supplements New Entrant and Capacity Expansion Plans
Table 65. Equine Pharmaceuticals and Supplements Mergers & Acquisitions in the Past Five Years
Table 66. Global Equine Pharmaceuticals and Supplements Sales by Region (2016-2021e) & (K Units)
Table 67. Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2026) & (K Units)
Table 68. Global Equine Pharmaceuticals and Supplements Revenue by Region (2016-2021e) & (USD Million)
Table 69. Global Equine Pharmaceuticals and Supplements Revenue by Region (2021-2026) & (USD Million)
Table 70. Global Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 71. Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 72. Global Equine Pharmaceuticals and Supplements Revenue by Type (2016-2021e) & (USD Million)
Table 73. Global Equine Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (USD Million)
Table 74. Global Equine Pharmaceuticals and Supplements Price by Type (2016-2021e) & (USD/Unit)
Table 75. Global Equine Pharmaceuticals and Supplements Price by Type (2021-2026) & (USD/Unit)
Table 76. Global Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 77. Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 78. Global Equine Pharmaceuticals and Supplements Revenue by Application (2016-2021e) & (USD Million)
Table 79. Global Equine Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (USD Million)
Table 80. Global Equine Pharmaceuticals and Supplements Price by Application (2016-2021e) & (USD/Unit)
Table 81. Global Equine Pharmaceuticals and Supplements Price by Application (2021-2026) & (USD/Unit)
Table 82. North America Equine Pharmaceuticals and Supplements Sales by Country (2016-2021e) & (K Units)
Table 83. North America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)
Table 84. North America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 85. North America Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (USD Million)
Table 86. North America Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 87. North America Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 88. North America Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 89. North America Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 90. Europe Equine Pharmaceuticals and Supplements Sales by Country (2016-2021e) & (K Units)
Table 91. Europe Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)
Table 92. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 93. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (USD Million)
Table 94. Europe Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 95. Europe Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 96. Europe Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 97. Europe Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 98. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2016-2021e) & (K Units)
Table 99. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2021-2026) & (K Units)
Table 100. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2016-2021e) & (USD Million)
Table 101. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 103. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 104. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 105. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 106. South America Equine Pharmaceuticals and Supplements Sales by Country (2016-2021e) & (K Units)
Table 107. South America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)
Table 108. South America Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 109. South America Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (USD Million)
Table 110. South America Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 111. South America Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 112. South America Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 113. South America Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 114. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2016-2021e) & (K Units)
Table 115. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)
Table 116. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2016-2021e) & (USD Million)
Table 117. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2016-2021e) & (K Units)
Table 119. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units)
Table 120. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2016-2021e) & (K Units)
Table 121. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units)
Table 122. Direct Channel Pros & Cons
Table 123. Indirect Channel Pros & Cons
Table 124. Equine Pharmaceuticals and Supplements Typical Distributors
Table 125. Equine Pharmaceuticals and Supplements Typical Customers
List of Figures
Figure 1. Equine Pharmaceuticals and Supplements Picture
Figure 2. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2020
Figure 3. Pharmaceuticals
Figure 4. Supplements
Figure 5. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2020
Figure 6. Thoroughbred Horse
Figure 7. Other Types of Horses
Figure 8. Global Equine Pharmaceuticals and Supplements Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Equine Pharmaceuticals and Supplements Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Equine Pharmaceuticals and Supplements Sales (2016-2026) & (K Units)
Figure 11. Global Equine Pharmaceuticals and Supplements Price by Type (2016-2026) & (USD/Unit)
Figure 12. Global Equine Pharmaceuticals and Supplements Production Capacity (2016-2026) & (K Units)
Figure 13. Global Equine Pharmaceuticals and Supplements Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Equine Pharmaceuticals and Supplements Market Drivers
Figure 15. Equine Pharmaceuticals and Supplements Market Restraints
Figure 16. Equine Pharmaceuticals and Supplements Market Trends
Figure 17. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturer in 2020
Figure 18. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturer in 2020
Figure 19. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Equine Pharmaceuticals and Supplements Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Equine Pharmaceuticals and Supplements Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2026)
Figure 23. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2016-2026)
Figure 24. North America Equine Pharmaceuticals and Supplements Revenue (2016-2026) & (USD Million)
Figure 25. Europe Equine Pharmaceuticals and Supplements Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue (2016-2026) & (USD Million)
Figure 27. South America Equine Pharmaceuticals and Supplements Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue (2016-2026) & (USD Million)
Figure 29. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2026)
Figure 30. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2016-2026)
Figure 31. Global Equine Pharmaceuticals and Supplements Price by Type (2016-2026) & (USD/Unit)
Figure 32. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 33. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2016-2026)
Figure 34. Global Equine Pharmaceuticals and Supplements Price by Application (2016-2026) & (USD/Unit)
Figure 35. North America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2026)
Figure 36. North America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 37. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2026)
Figure 38. North America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2026)
Figure 39. United States Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2026)
Figure 43. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 44. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2026)
Figure 45. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2026)
Figure 46. Germany Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2016-2026)
Figure 55. China Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2026)
Figure 62. South America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 63. South America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2026)
Figure 64. South America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Equine Pharmaceuticals and Supplements Revenue and Growth

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs